Literature DB >> 22184322

Cyp2c44 epoxygenase is essential for preventing the renal sodium absorption during increasing dietary potassium intake.

Peng Sun1, Joseph Antoun, Dao-Hong Lin, Peng Yue, Katherine H Gotlinger, Jorge Capdevila, Wen-Hui Wang.   

Abstract

The aim of this study is to test whether the Cyp2c44 epoxygenase-dependent metabolism of arachidonic acid prevents the hypertensive effect of a high K (HK) intake by inhibiting the epithelial sodium channel (ENaC) activity. A HK intake elevated Cyp2c44 mRNA expression and 11,12-epoxyeicosatrienoic acid levels in the cortical collecting duct in Cyp2c44(+/+) mice (wild-type [wt]). However, an HK intake failed to increase 11,12-epoxyeicosatrienoic acid formation in the cortical collecting ducts of Cyp2c44(-/-) mice. Moreover, increasing K intake enhanced arachidonic acid-induced inhibition of ENaC in the wt but not in Cyp2c44(-/-) mice. In contrast, 11,12-epoxyeicosatrienoic acid, a Cyp2c44 metabolite, inhibited ENaC in the wt and Cyp2c44(-/-) mice. The notion that Cyp2c44 is the epoxygenase responsible for mediating the inhibitory effects of arachidonic acid on ENaC is further suggested by the observation that inhibiting Cyp-epoxygenase increased the whole-cell Na currents in principal cells of wt but not in Cyp2c44(-/-) mice. Feeding mice with an HK diet raised the systemic blood pressures of Cyp2c44(-/-) mice but was without an effect on wt mice. Moreover, application of amiloride abolished the HK-induced hypertension in Cyp2c44(-/-) mice. The HK-induced hypertension of Cyp2c44(-/-) mice was accompanied by decreasing 24-hour urinary Na excretion and increasing the plasma Na concentration, and the effects were absent in wt mice. In contrast, disruption of the Cyp2c44 gene did not alter K excretion. We conclude that Cyp2c44 epoxygenase mediates the inhibitory effect of arachidonic acid on ENaC and that Cyp2c44 functions as an HK-inducible antihypertensive enzyme responsible for inhibiting ENaC activity and Na absorption in the aldosterone-sensitive distal nephron.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22184322      PMCID: PMC3382086          DOI: 10.1161/HYPERTENSIONAHA.111.178475

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  38 in total

1.  Regulation of small-conductance K+ channel in apical membrane of rat cortical collecting tubule.

Authors:  W H Wang; A Schwab; G Giebisch
Journal:  Am J Physiol       Date:  1990-09

2.  Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension.

Authors:  Xueying Zhao; David M Pollock; Edward W Inscho; Darryl C Zeldin; John D Imig
Journal:  Hypertension       Date:  2002-12-16       Impact factor: 10.190

Review 3.  P-450 metabolites of arachidonic acid in the control of cardiovascular function.

Authors:  Richard J Roman
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

4.  Actions of epoxygenase metabolites on the preglomerular vasculature.

Authors:  J D Imig; L G Navar; R J Roman; K K Reddy; J R Falck
Journal:  J Am Soc Nephrol       Date:  1996-11       Impact factor: 10.121

5.  Aldosterone induces a rapid increase in the rate of Na,K-ATPase gene transcription in cultured kidney cells.

Authors:  F Verrey; J P Kraehenbuhl; B C Rossier
Journal:  Mol Endocrinol       Date:  1989-09

6.  Effect of dietary potassium on blood pressure, renal function, muscle sympathetic nerve activity, and forearm vascular resistance and flow in normotensive and borderline hypertensive humans.

Authors:  W J Lawton; A E Fitz; E A Anderson; C A Sinkey; R A Coleman
Journal:  Circulation       Date:  1990-01       Impact factor: 29.690

7.  Modulation of renal sodium-potassium-adenosine triphosphatase by aldosterone. Effect of high physiologic levels on enzyme activity in isolated rat and rabbit tubules.

Authors:  S K Mujais; M A Chekal; W J Jones; J P Hayslett; A I Katz
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

8.  High potassium intake selectively increases urinary PGF2 alpha excretion in the rat.

Authors:  A Nasjletti; A Erman; L M Cagen; D P Brooks; J T Crofton; L Share; P G Baer
Journal:  Am J Physiol       Date:  1985-03

9.  High potassium intake increases the plasma concentration and urinary excretion of vasopressin in the rat.

Authors:  D P Brooks; J T Crofton; L Share; A Nasjletti
Journal:  Experientia       Date:  1986-09-15

10.  5,6-EET inhibits ion transport in collecting duct by stimulating endogenous prostaglandin synthesis.

Authors:  Y Sakairi; H R Jacobson; T D Noland; J H Capdevila; J R Falck; M D Breyer
Journal:  Am J Physiol       Date:  1995-05
View more
  22 in total

Review 1.  Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.

Authors:  Fan Fan; Richard J Roman
Journal:  J Am Soc Nephrol       Date:  2017-07-12       Impact factor: 10.121

2.  The arachidonic acid monooxygenase: from biochemical curiosity to physiological/pathophysiological significance.

Authors:  Jorge H Capdevila; John R Falck
Journal:  J Lipid Res       Date:  2018-08-28       Impact factor: 5.922

3.  Role of Müller cell cytochrome P450 2c44 in murine retinal angiogenesis.

Authors:  Jiong Hu; Alexandra Geyer; Sarah Dziumbla; Khader Awwad; Darryl C Zeldin; Wolf-Hagen Schunck; Rüdiger Popp; Timo Frömel; Ingrid Fleming
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-04-23       Impact factor: 3.072

Review 4.  Epoxyeicosatrienoic acids, hypertension, and kidney injury.

Authors:  John D Imig
Journal:  Hypertension       Date:  2015-01-12       Impact factor: 10.190

5.  Role of epoxyeicosatrienoic acids (EETs) in mediation of dopamine's effects in the kidney.

Authors:  Ming-Zhi Zhang; Yinqiu Wang; Bing Yao; Leslie Gewin; Shouzuo Wei; Jorge H Capdevila; Raymond C Harris
Journal:  Am J Physiol Renal Physiol       Date:  2013-10-23

6.  Midkine Regulates BP through Cytochrome P450-Derived Eicosanoids.

Authors:  Yuka Sato; Waichi Sato; Shoichi Maruyama; Christopher S Wilcox; John R Falck; Tomohiro Masuda; Tomoki Kosugi; Hiroshi Kojima; Kayaho Maeda; Kazuhiro Furuhashi; Masahiko Ando; Enyu Imai; Seiichi Matsuo; Kenji Kadomatsu
Journal:  J Am Soc Nephrol       Date:  2014-11-05       Impact factor: 10.121

7.  Cyp2c44 epoxygenase in the collecting duct is essential for the high K+ intake-induced antihypertensive effect.

Authors:  Wen-Hui Wang; Chengbiao Zhang; Dao-Hong Lin; Lijun Wang; Joan P Graves; Darryl C Zeldin; Jorge H Capdevila
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-25

8.  The Cyp2c44 epoxygenase regulates epithelial sodium channel activity and the blood pressure responses to increased dietary salt.

Authors:  Jorge H Capdevila; Nataliya Pidkovka; Shaojun Mei; Yan Gong; John R Falck; John D Imig; Raymond C Harris; Wenhui Wang
Journal:  J Biol Chem       Date:  2013-12-24       Impact factor: 5.157

9.  Cyp2c44 gene disruption exacerbated pulmonary hypertension and heart failure in female but not male mice.

Authors:  Sachindra Raj Joshi; Anand Lakhkar; Vidhi Dhagia; Ariadne L Zias; Vasiliki Soldatos; Kaori Oshima; Houli Jiang; Katherine Gotlinger; Jorge H Capdevila; Michal L Schwartzman; Ivan F McMurtry; Sachin A Gupte
Journal:  Pulm Circ       Date:  2016-09       Impact factor: 3.017

10.  Orally active epoxyeicosatrienoic acid analog attenuates kidney injury in hypertensive Dahl salt-sensitive rat.

Authors:  Md Abdul Hye Khan; Jan Neckár; Vijay Manthati; Ramu Errabelli; Tengis S Pavlov; Alexander Staruschenko; John R Falck; John D Imig
Journal:  Hypertension       Date:  2013-08-26       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.